Phase 1 trial findings showed that GD2-CAR T-cell therapy induced significant tumor regressions and neurological improvements in patients with H3K27M-mutant diffuse midline gliomas. A phase 1 clinical ...

Developed by University of Michigan and University of California San Francisco researchers, the technology is called FastGlioma – incorporating the term 'glioma' that refers to a brain or spinal ...

When a doctor suspects a patient may have a glioma, they will perform a thorough workup to get an accurate diagnosis in order to tailor treatment to the patient and cancer. The first step is a ...